282
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Correlation Between Health Risk Factors and Diabesity and Lipid Profile Indicators: The Role Mediator of TSH

, , , , , & show all
Pages 1247-1259 | Received 18 Nov 2022, Accepted 02 Mar 2023, Published online: 02 May 2023

References

  • Sutkowska E, Sutkowski K, Sokolowski M, Franek E, Dragan SS. Distribution of the highest plantar pressure regions in patients with diabetes and its association with peripheral neuropathy, gender, age, and BMI: one centre study. J Diabetes Res. 2019;2019:7395769. doi:10.1155/2019/7395769
  • Riobo SP. Obesity and diabetes. Nutr Hosp. 2013;28(Suppl 5):138–143. doi:10.3305/nh.2013.28.sup5.6929
  • Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735.
  • Wang X, Liu J, Cheng Z, et al. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study. Lipids Health Dis. 2021;20(1):99.
  • Zou S, Yang C, Shen R, et al. Association between the triglyceride-glucose index and the incidence of diabetes in people with different phenotypes of obesity: a retrospective study. Front Endocrinol. 2021;12:784616.
  • Zeng ZY, Liu SX, Xu H, et al. Association of triglyceride glucose index and its combination of obesity indices with prehypertension in lean individuals: a cross-sectional study of Chinese adults. J Clin Hypertens. 2020;22(6):1025–1032.
  • Jeong S, Lee JH. The verification of the reliability of a triglyceride-glucose index and its availability as an advanced tool. Metabolomics. 2021;17(11):97.
  • Liu EQ, Weng YP, Zhou AM, Zeng CL. Association between triglyceride-glucose index and type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study. Biomed Res Int. 2020;2020:2947067.
  • Jun JE, Jee JH, Bae JC, et al. Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study. Thyroid. 2017;27(1):29–38.
  • Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):408–413. doi:10.1097/MED.0b013e328355cd6c
  • Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013;5(Suppl1):40–44. doi:10.4274/jcrpe.856
  • Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disorders. Endokrynol Pol. 2014;65(1):70–76. doi:10.5603/EP.2014.0010
  • Rai S, Kumar JA, K P, et al. Thyroid function in type 2 diabetes mellitus and in diabetic nephropathy. J Clin Diagn Res. 2013;7(8):1583–1585. doi:10.7860/JCDR/2013/6216.3299
  • Jiang T, Zhang Y, Dai F, et al. Advanced glycation end products and diabetes and other metabolic indicators. Diabetol Metab Syndr. 2022;14(1):104. doi:10.1186/s13098-022-00873-2
  • Zhang Y, Jiang T, Liu C, et al. Effectiveness of early advanced glycation end product accumulation testing in the diagnosis of diabetes: a health risk factor analysis using the body mass index as a moderator. Front Endocrinol. 2022;12:766778. doi:10.3389/fendo.2021.766778
  • Zhou B-F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
  • Chalmers J. 1999 World Health Organization-international society of hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens. 1999;17(2):151–183.
  • Fouad M, Fathy H, Zidan A. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients. Jornal Brasileiro de Nefrologia. 2016;38(4):403–410. doi:10.5935/0101-2800.20160065
  • Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012;35(1):99–104. doi:10.2337/dc11-1346
  • Alwakeel JS, Isnani AC, Alsuwaida A, et al. Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia. Ann Saudi Med. 2011;31(3):236–242. doi:10.4103/0256-4947.81528
  • Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S79–83.
  • Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther. 2017;98:39–57.
  • Hausdorf K, Eakin E, Whiteman D, et al. Prevalence and correlates of multiple cancer risk behaviors in an Australian population-based survey: results from the Queensland cancer risk study. Cancer Causes Control. 2008;19(10):1339–1347.
  • Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ. 2010;340:b4838.
  • Walczak K, Sieminska L. Obesity and thyroid axis. Int J Environ Res Public Health. 2021;18(18):1.
  • Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):453.
  • Iglay K, Hannachi H, Joseph HP, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243–1252.
  • Thijssen DH, Carter SE, Green DJ. Arterial structure and function in vascular ageing: are you as old as your arteries? J Physiol. 2016;594(8):2275–2284.
  • Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex/gender differences in obesity prevalence, comorbidities, and treatment. Curr Obes Rep. 2021;10(4):458–466.
  • Theilade S, Christensen MB, Vilsboll T, Knop FK. An overview of obesity mechanisms in humans: endocrine regulation of food intake, eating behaviour and common determinants of body weight. Diabetes Obes Metab. 2021;23(Suppl 1):17–35.
  • Zupo R, Castellana F, Panza F, et al. Adherence to a Mediterranean diet and thyroid function in obesity: a cross-sectional apulian survey. Nutrients. 2020;12:10.
  • Liu N, Ma F, Feng Y, Ma X. The association between the dietary inflammatory index and thyroid function in U.S. adult males. Nutrients. 2021;13:10.
  • Hariharan R, Odjidja EN, Scott D, et al. The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases. Obes Rev. 2022;23(1):e13349.
  • Mehran L, Amouzegar A, Rahimabad PK, et al. Thyroid function and metabolic syndrome: a population-based thyroid study. Horm Metab Res. 2017;49(3):192–200.
  • Volke L, Krause K. Effect of thyroid hormones on adipose tissue flexibility. Eur Thyroid J. 2021;10(1):1–9.
  • Christoffolete MA, Linardi CC, de Jesus L, et al. Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes. 2004;53(3):577–584.
  • Lombardi A, de Lange P, Silvestri E, et al. 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement. Am J Physiol Endocrinol Metab. 2009;296(3):E497–502.
  • He J, Lai Y, Yang J, et al. The relationship between thyroid function and metabolic syndrome and its components: a cross-sectional study in a Chinese population. Front Endocrinol. 2021;12:661160.
  • Han Q, Zhang J, Wang Y, et al. Thyroid hormones and diabetic nephropathy: an essential relationship to recognize. Nephrology. 2019;24(2):160–169.
  • Rosique-Esteban N, Papandreou C, Romaguera D, et al. Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial. Sleep. 2018;41:12.
  • Ortega MA, Fraile-Martinez O, Naya I, et al. Type 2 diabetes mellitus associated with obesity (diabesity). the central role of gut microbiota and its translational applications. Nutrients. 2020;12:9.